Rongzhe Liu

6PUBLICATIONS
17CO-AUTHORS
Respiratory diseasesCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapyMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 18, 2023
Population Health Model Predicting the Long-Term Impact of Sotatercept on Morbidity and Mortality in Patients with Pulmonary Arterial Hypertension (PAH).

Vallerie McLaughlin, Adnan Alsumali, Rongzhe Liu

|Apr 21, 2022
Cost-effectiveness of axicabtagene ciloleucel versus lisocabtagene maraleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the US.

Olalekan O Oluwole, Rongzhe Liu, Ibrahim Diakite

|Mar 31, 2022
Real-world cost-effectiveness of primary prophylaxis with G-CSF biosimilars in patients at intermediate/high risk of febrile neutropenia.

Paul Cornes, John Kelton, Rongzhe Liu

|Oct 08, 2021
Cost Effectiveness of Vericiguat for the Treatment of Chronic Heart Failure with Reduced Ejection Fraction Following a Worsening Heart Failure Event from a US Medicare Perspective.

Adnan Alsumali, Laurence M Djatche, Andrew Briggs

|Apr 27, 2021
Biosimilar pegfilgrastim may offer affordable treatment options for patients in France: a budget impact analysis on the basis of clinical trial and real-world data.

Jingyan Yang, Rongzhe Liu, Anna Granghaud

|Mar 11, 2021
Cost effectiveness of axicabtagene ciloleucel versus tisagenlecleucel for adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy in the United States.

Rongzhe Liu, Olalekan O Oluwole, Ibrahim Diakite

Pageof 1

Frequent Collaborators

3 joint publications

Ibrahim Diakite

2 joint publications

Olalekan O Oluwole

2 joint publications

Julia Thornton Snider

2 joint publications

Frederick L Locke